Elena Feinstein
Technik-/Wissenschafts-/F&E-Leiter bei Quark Pharmaceuticals, Inc.
Aktive Positionen von Elena Feinstein
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 | - |
Karriereverlauf von Elena Feinstein
Ausbildung von Elena Feinstein
| Moscow University | Doctorate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 2 |
| Russland | 2 |
| Israel | 2 |
Operativ
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Börse
- Insiders
- Elena Feinstein
- Erfahrung
